Northwestern University Feinberg School of Medicine
Skip to main content

Translational Research in Malignancy Members

The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.

Wei, Jian-Jun

Bio

My research interests focus on the histological and phenotypical interpretation of human cancer. As a physician scientist trained in gynecological pathology, my research goal is to discover and develo... [more]

Weinstein, Joanna L.

Weinstein, Joanna L.

Associate Professor

Bio

My clinical and research areas of interest include RETINOBLASTOMA, LYMPHOMAS(both Non-Hodgkin and Hodgkin subtypes), and the HISTIOCYTOSES. Our retinoblastoma team includes oncologists, oph... [more]

Winter, Jane N.

Bio

Winter's clinical and research interests focus on the malignant lymphomas (both Hodgkin and non-Hodgkin), particularly the development of novel therapies and the investigation of clinical and biologic... [more]

Yang, Ximing

Yang, Ximing

Professor

Bio

General Surgical Pathology and Urological Surgical Pathology Diagnosis of genital urinary cancers including prostate, bladder, kidney, testis and other GU organs Immunohistochemistry Pathogenesis of p... [more]

Yue, Feng

Yue, Feng

Professor

Bio

The long-term goal of Dr. Yue's group is to use a combination of high throughput genomics, computational modeling, and functional assays to study how genetic variants contribute to the pathogenes... [more]

Zhang, Hui

Zhang, Hui

Professor

Bio

I am a biostatistician with about 10 years of oncology clinical trial experiences, including but not limited to the clinical design, clinical data analysis and statistical modeling. My statistical res... [more]

Zhou, Alan (Xiaolong)

Zhou, Alan (Xiaolong)

Assistant Professor

Bio

My goal is to use dermatology as a platform for studying and advancing genetics, immunology, and cancer biology. I have been fortunate to have a strong background in immunology, genetics and cell biol... [more]